Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

for the Osteoporosis Therapeutics Market 51

4.17.2 Barriers for the Postmenopausal Osteoporosis Therapeutics Market 52

4.18 Opportunity and Unmet Need 54

4.19 Key Takeaway 57

5 Osteoporosis Therapeutics: Competitive Assessment 58

5.1 Overview 58

5.2 Strategic Competitor Assessment 58

5.3 Product Profile for the Major Marketed Products in the Osteoporosis Therapeutics Market 60

5.3.1 Fosamax (alendronate sodium) 60

5.3.2 Actonel (risedronate sodium) 62

5.3.3 Boniva (ibandronate sodium) 64

5.3.4 Reclast (zoledronic acid) 66

5.3.5 Evista (raloxifene hydrochloride) 68

5.3.6 Prolia (denosumab) 70

5.3.7 Forteo (teriparatide [rDNA origin]) injection 71

5.3.8 Miacalcin (salmon calcitonin) 74

5.3.9 Activella (estradiol, norethindrone acetate) 75

5.3.10 Premarin (estrogen) 76

5.3.11 Prempro (conjugated estrogens and medroxyprogesterone acetate) 77

5.4 Key Takeaway 78

6 Osteoporosis Therapeutics: Pipeline Assessment 79

6.1 Overview 79

6.2 Strategic Pipeline Assessment 79

6.3 Osteoporosis Therapeutics – Pipeline Analysis by Clinical Phase of Development 79

6.3.1 Osteoporosis Therapeutics – Phase III and Regulatory Filed Clinical Pipeline 80

6.3.2 Osteoporosis Therapeutics – Phase II Clinical Pipeline 81

6.3.3 Osteoporosis Therapeutics – Phase I Pipeline 82

6.3.4 Osteoporosis Therapeutics –Pre-clinical and Discovery Phase Pipeline 83

6.4 Osteoporosis Therapeutics – Pipeline by Mechanism of Action 84

6.5 Technology Trends Analytical Framework 85

6.6 Osteoporosis Therapeutics – Most Promising Drugs in Clinical Development 87

6.7 Most Promising Drugs in Clinical Development 88

6.7.1 Viviant 88

6.7.2 Fablyn 89

6.7.3 Aprela 90

6.7.4 EX101 91

6.7.5 Odanacatib (MK-0822) 92

6.7.6 NB S101 93
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "Germany ... market data on the Germany Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... , Sept. 17, 2014  Dr. Stephen Loyd ... White House today for National Recovery Month, stars in ... advocates released today. Consumer advocates were also joined by ... spoke out after losing her fiancée because of a ... doctor had a history of crack cocaine abuse. Proposition ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 /PRNewswire/ ... disease/ulcerative colitis (CD/UC) patients eligible for biologic ... receive a biologic. Surveyed gastroenterologists cite patients, ... reason for low penetration rates, followed by ... and UC patients receiving biologics, Janssen Biotech,s ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
(Date:9/17/2014)... Recently, UWDress.com, an innovative company that provides many kinds ... released its 2014 empire waist evening dress ... big sale for these new and beautiful products. All ... from 15 to 65 percent off. , It ... to wear materials. Its elegant items include gold empire ...
(Date:9/17/2014)... September 18, 2014 IntimateRider, an inventor ... adults , has announced that it has entered into ... & Mobility LLC. A primary reason for the deal ... distribution reach is global. About its sales potential, representatives ... to provide you with the latest products on the ...
(Date:9/17/2014)... September 18, 2014 iFitDress.com, a renowned wedding ... of petite evening dresses . All these outfits are ... and discounted shipping costs. , “iFitDress.com is a professional ... gowns. We are now busy selling our new collection of ... place an order above $800 can get free shipping. All ...
(Date:9/17/2014)... September 18, 2014 The National Resident ... Match , a comprehensive analysis of the relationship between ... preferred specialty. The new edition is based on ... specialty for U.S. allopathic medical school senior students and ... be able to provide this new edition of Charting ...
(Date:9/17/2014)... Columbus, Ohio (PRWEB) September 18, 2014 ... cycle management services nationwide, announces today that they ... Fort Wayne Radiology (FWRadiology) in Fort Wayne, Indiana. ... range of billing services encompassing their proprietary suite ... Technology (EBT). EBT improves radiology billing and ...
Breaking Medicine News(10 mins):Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3Health News:Elegant Petite Evening Dresses Introduced By Renowned Supplier iFitDress.com 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 3Health News:ADVOCATE Wins Radiology Billing Agreements with Fort Wayne Radiology 2Health News:ADVOCATE Wins Radiology Billing Agreements with Fort Wayne Radiology 3
... ... 10 NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ), a ... President and Chief Financial Officer will be interviewed live on FOXBusiness.com LIVE on ... www.foxbusiness.com/live on Friday, December 11, 2009 between 12 and ...
... , ... know much about depression , but are highly aware of ... by the National Alliance on Mental Illness (NAMI). ... Web site that includes resources for people of diverse communities. , ...
... that tuberculosis bacteria use to coerce disease-fighting cells to ... line the airways and other surfaces to protect and ... into helping create tubercles: the small, rounded masses characteristic ... their numbers and spread to other locations. ...
... ... Laser-type device to be coupled with Stem Cell Therapy in Novel ... San Diego (PRWEB) December 10, 2009 -- Entest Biomedical Inc. ... with Advanced Light Devices to develop a proprietary laser system. It is anticipated this investigational medical device will ...
... , New report notes that ... could decline by 36 percent , Oak Brook, Ill., ... (ASGE) lauds the recent news of the decline in U.S. colorectal ... that from 1975 to 2000, incidence rates dropped 22 percent and ...
... alcoholic beverages (at least three to four drinks per week, ... 30 percent increased risk of breast cancer recurrence, according to ... be most susceptible to the effects of alcohol on recurrence, ... this study will be presented December 9-13 at the Cancer ...
Cached Medicine News:Health News:NBTY to be Featured on the FOX Business Program FOXBusiness.com LIVE 2Health News:Depression Survey: Implications for Diverse Communities 2Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 2Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 3Health News:Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment 2Health News:Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment 3Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 2Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 3Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 4Health News:Alcohol consumption may increase breast cancer recurrence risk 2
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: